Combined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer
{{output}}
Importance: The KEYNOTE-689 trial demonstrated improved event-free survival with the addition of perioperative pembrolizumab to standard of care for patients with locally advanced head and neck squamous cell carcinoma (HNSCC), ye... ...
